Preadipocyte Factor-1 Levels Are Higher in Women with Hypothalamic Amenorrhea and Are Associated with Bone Mineral Content and Bone Mineral Density through a Mechanism Independent of Leptin
Open Access
- 1 October 2011
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 96 (10) , E1634-E1639
Abstract
Context: Preadipocyte factor 1 (pref-1) is increased in anorexia nervosa and is associated negatively with bone mineral density (BMD). No previous studies exist on pref-1 in women with exercise-induced hypothalamic amenorrhea (HA), which similar to anorexia nervosa, is an energy-deficiency state associated with hypoleptinemia. Objective: Our objective was to evaluate whether pref-1 levels are also elevated and associated with low BMD and to assess whether leptin regulates pref-1 levels in women with HA. Design: Study 1 was a double-blinded, placebo-controlled randomized clinical trial of metreleptin administration in women with HA. Study 2 was an open-label study of metreleptin administration in low physiological, supraphysiological, and pharmacological doses in healthy women volunteers. Setting and Patients: At Beth Israel Deaconess Medical Center, 20 women with HA and leptin levels higher than 5 ng/ml and nine healthy control women participated in study 1, and five healthy women participated in study 2. Intervention: For study 1, 20 HA subjects were randomized to receive either 0.08 mg/kg metreleptin (n = 11) or placebo (n = 9). For study 2, five healthy subjects received 0.01, 0.1, and 0.3 mg/kg metreleptin in both fed and fasting conditions for 1 and 3 d, respectively. Main Outcome Measures: Circulating pref-1 and leptin levels were measured. Results: Pref-1 was significantly higher in HA subjects vs. controls (P = 0.035) and negatively associated with BMD (ρ = −0.38; P < 0.01) and bone mineral content (ρ = −0.32; P < 0.05). Metreleptin administration did not alter pref-1 levels in any study reported herein. Conclusions: Pref-1 is higher in HA subjects than controls. Metreleptin administration at low physiological, supraphysiological, and pharmacological doses does not affect pref-1 levels, suggesting that hypoleptinemia is not responsible for higher pref-1 levels and that leptin does not regulate pref-1.Keywords
This publication has 21 references indexed in Scilit:
- Leptin is an effective treatment for hypothalamic amenorrheaProceedings of the National Academy of Sciences, 2011
- Recombinant Human Leptin in Women with Hypothalamic AmenorrheaNew England Journal of Medicine, 2004
- Leptin Hormonal Kinetics in the Fed State: Effects of Adiposity, Age, and Gender on Endogenous Leptin Production and Clearance RatesThe Journal of Clinical Endocrinology & Metabolism, 2004
- Relationship of Leptin to Bone Mineralization in Children and AdolescentsThe Journal of Clinical Endocrinology & Metabolism, 2003
- Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiencyJournal of Clinical Investigation, 2002
- Role of Leptin in ReproductionAnnals of the New York Academy of Sciences, 2000
- Amenorrheic Bone Loss 1The Journal of Clinical Endocrinology & Metabolism, 1999
- Functional Hypothalamic Amenorrhea: Hypoleptinemia and Disordered EatingThe Journal of Clinical Endocrinology & Metabolism, 1999
- Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell culturesJournal of Cell Science, 1992
- Adult-onset amenorrhea: A study of 262 patientsAmerican Journal of Obstetrics and Gynecology, 1986